Related Experiment Video
Updated: Jun 16, 2026

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Dentinogenic Ghost Cell Tumor in an Elderly Female: A Rare Case Report
Akunchan Shrestha1, Iccha Kumar Maharjan1, Pragya Regmee1
1Department of Oral Medicine and Radiology, College of Dental Surgery, B.P. Koirala Institute of Health Sciences, Dharan, Nepal, bpkihs.edu.
None:
Dentinogenic ghost cell tumor (DGCT) is an uncommon odontogenic neoplasm that accounts for less than 0.5% of all tumors with odontogenic origin. Its rarity, along with identical radiological and clinical features as other odontogenic lesions, often makes the diagnosis challenging. The current case report discusses the clinical, radiological, and histopathological features of DGCT in a 71-year-old female patient presenting with facial swelling and pain in the maxillary anterior region. Clinical examination revealed a hard, tender, localized swelling from the infraorbital to the zygomatic regions. Intraoral exam revealed a sessile swelling buccopalatally extending and involving the labial vestibule and hard palate. Imaging showed a unilocular, expansile lytic lesion with hyperdense contents and a thinned cortex, suggestive of odontogenic pathology. Histopathology confirmed the diagnosis of DGCT on the basis of ghost cells with calcification, ameloblastoma-like epithelial islands, and dentinoid material in connective tissue. Treatment was done by wide local excision with a maxillary obturator prosthesis. Six-month postoperative follow-up showed no recurrence or complication. This case highlights the importance of combining clinical, radiological, and histopathological examination to diagnose rare odontogenic tumors like DGCT. Despite being benign, the tumor's aggressive potential demands radical resection and extended follow-up for monitoring recurrence. The case also highlights the importance of raising awareness among clinicians to achieve optimum diagnostic yield and patient outcomes.

